CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $710K invested in Can-Fite BioPharma in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

67% less capital invested

Capital invested by funds: $2.18M → $710K (-$1.47M)

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$190K
2
+$112K
3
+$42K
4
MC
Menta Capital
California
+$27K
5
Goldman Sachs
Goldman Sachs
New York
+$23K

Top Sellers

1
-$853K
2
-$234K
3
-$5K
4
TRCT
Tower Research Capital (TRC)
New York
-$2K
5
BRWA
B. Riley Wealth Advisors
Florida
-$4
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$265K
2
$190K
3
$112K
4
$42K
5
$27K
6
$23K
7
$23K
8
$16K
9
$5K
10
$4K
11
$2K
12
$1K
13
–
14
–